retatrutide obesity phase 2 trial This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial https://t.co/jNL1GNnHPT #Endocrinology Retatrutide for the treatment of

When new treatments are approved, we will evaluate them for inclusion in our clinical protocols based on the evidence, not the hype

Higher price reflects packaging and lot consistency

"Not only could a liraglutide generic boost the patient population able to access GLP-1Ras, but it could also allow patients to switch from branded drugs to an older generic if a lower-efficacy product is sufficient." Though it is yet to be seen if liraglutide will become a favourable choice for prescribers and patients alike, Aliciati stated that the generic approval will likely have no impact on sales of Wegovy and Zepbound, as "some patients will still require higher weight loss efficacy than what is offered by liraglutide".

Plant Physiol 146:12821292 Lu S, Su W, Li H, Guo Z (2009) Abscisic acid improves drought tolerance of triploid bermudagrass and involves H 2 O 2 - and NO-induced antioxidant enzyme activities

Drug interaction studies with psychiatric medications are essential before any clinical use